Omega Healthcare Investors, Inc. (NYSE:OHI) Stock Holdings Decreased by Gentry Private Wealth LLC

Gentry Private Wealth LLC lowered its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 4.5% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 11,015 shares of the real estate investment trust’s stock after selling 522 shares during the period. Gentry Private Wealth LLC’s holdings in Omega Healthcare Investors were worth $448,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Daiwa Securities Group Inc. raised its stake in Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after acquiring an additional 3,003,845 shares during the period. Penserra Capital Management LLC raised its stake in Omega Healthcare Investors by 22.6% during the third quarter. Penserra Capital Management LLC now owns 38,716 shares of the real estate investment trust’s stock worth $1,575,000 after acquiring an additional 7,130 shares during the period. Cerity Partners LLC raised its stake in Omega Healthcare Investors by 99.6% during the third quarter. Cerity Partners LLC now owns 277,031 shares of the real estate investment trust’s stock worth $11,275,000 after acquiring an additional 138,208 shares during the period. Meridian Wealth Management LLC acquired a new stake in Omega Healthcare Investors during the third quarter worth about $235,000. Finally, Citigroup Inc. raised its stake in Omega Healthcare Investors by 20.1% during the third quarter. Citigroup Inc. now owns 351,529 shares of the real estate investment trust’s stock worth $14,307,000 after acquiring an additional 58,950 shares during the period. Institutional investors own 65.25% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on OHI. Scotiabank increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. BMO Capital Markets raised their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a research note on Friday, October 18th. They issued a “buy” rating and a $45.00 price target on the stock. Truist Financial raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, September 4th. Finally, BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research note on Thursday, October 31st. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $40.00.

Insider Activity at Omega Healthcare Investors

In related news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Price Performance

NYSE OHI opened at $40.11 on Friday. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The firm has a market capitalization of $10.83 billion, a PE ratio of 29.49, a P/E/G ratio of 1.25 and a beta of 0.99. The company’s 50 day simple moving average is $40.62 and its 200 day simple moving average is $37.01.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a dividend of $0.67 per share. The ex-dividend date was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.68%. Omega Healthcare Investors’s dividend payout ratio is presently 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.